NSE: ARVEE
ARVEE LABORATORIES I LTD
Makes and sells chemical products through its Non-Textile Segment, which generated ₹27.58 crore in FY26, or 85.7% of segment revenue. The smaller Textile Segment contributed ₹4.62 crore, or 14.3% of segment revenue, in the same period. For FY26 as a whole, the company reported total income of ₹3,219.52 lakhs, down from ₹3,914.45 lakhs in the prior year, while profit after tax rose to ₹252.63 lakhs from ₹214.74 lakhs on lower raw material consumption. Raw materials are the dominant cost, accounting for 57.7% of revenue, followed by other operating expenses at 29.1% and employee costs at 14.2%. The Non-Textile Segment was also the more profitable, with EBIT of ₹2.20 crore versus ₹0.38 crore in the Textile Segment. The business is small-scale, with total assets of ₹43.26 crore at FY26 and operations based in Ahmedabad, Gujarat. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Non-Textile Segment (Chemicals) (86%), Textile Segment (14%). Small-scale specialty chemicals maker with a secondary textile business
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · standalone | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 40 | 62 | 30 | 38 | 32 |
| EBITDA (ex other income) | 6 | 8 | 3 | 4 | 3 |
| margin % | 14.0 | 13.5 | 9.9 | 9.4 | 10.1 |
| Owners' profit | 0 | 4 | 1 | 2 | 3 |
| EPS, as reported (₹) | 2.34 | 3.74 | 0.95 | 1.95 | 2.29 |
| ROE % · ROCE % | — · — | 14.7 · 22.2 | 3.6 · 6.7 | 6.9 · 9.3 | 7.5 · 7.5 |
| Debt / equity (x) | — | 0.04 | 0.03 | 0.03 | 0.03 |
| Cash from operations | 4 | 2 | 7 | (0) | (0) |
| Capex | 0 | (1) | (3) | (2) | (3) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13 | 9 | 6 | 7 | 3 | 10 | 11 | 17 |
| Profit before tax | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
| Net profit | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 2 |
| EPS (₹) | 0.89 | 0.14 | 0.06 | 0.15 | 0.01 | 1.66 | 0.47 | 1.54 |
Exhibit 3: Segment revenue, FY26
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Textile Segment | 3 | 13.2 |
| Non-Textile Segment | 9 | 44.5 |
| Non - Textile Segment | 9 | 42.3 |
| Total, before eliminations | 21 | 100.0 |
Exhibit 4: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| PIDILITE INDUSTRIES LTD | 1,42,095 | 53.6 | 12.86 | 37.6 | 22.4 | 28.0 | 14.9 | 28.6 |
| SRF LTD | 69,659 | 32.2 | 4.96 | 21.6 | 13.1 | 13.1 | 13.4 | 25.2 |
| GUJARAT FLUOROCHEM LTD | 47,075 | 76.8 | 5.95 | 37.4 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,610 | 55.1 | 10.97 | 39.3 | 16.7 | 16.4 | 23.0 | 37.5 |
| AETHER INDUSTRIES LIMITED | 20,905 | 88.6 | 8.51 | 56.8 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 20,257 | 25.9 | 3.45 | 21.0 | 9.4 | 10.2 | 12.6 | 21.5 |
| AARTI INDUSTRIES LTD | 15,871 | 29.9 | 2.67 | 17.1 | 7.0 | 4.4 | 13.0 | 16.2 |
| FINE ORGANIC IND. LTD. | 15,604 | 35.6 | 5.86 | 25.5 | 15.7 | 20.0 | 15.9 | 28.8 |
Exhibit 5: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 51.0 | 23.1 | 76 of 99 | 24% |
| P/B | 6.1 | 2.8 | 83 of 99 | 16% |
| ROCE | 6.8 | 10.1 | 66 of 106 | 38% |
| ROE | 7.5 | 8.1 | 55 of 99 | 45% |
| Debt / Equity | 0.0 | 0.2 | 29 of 99 | 71% |
| EBITDA margin | 15.5 | 15.5 | 50 of 99 | 50% |
| Revenue growth | 130.3 | 24.4 | 5 of 94 | 96% |
| Profit growth | 901.9 | 55.1 | 4 of 92 | 97% |
| Market cap | 207 | 699 | 72 of 108 | 34% |
Exhibit 6: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 15 Oct 2026 · Arvee Labs fined about Rs 11,800 by NSE for late Reg 44 filing | regulatory legal | low | — | — |
| 30 Sept 2026 · Arvee Labs AGM 2026 results: all 4 resolutions passed with 100 percent approval | compliance | minimal | — | — |
| 29 Sept 2026 · Arvee Labs holds 14th AGM; financials adopted, directors re-appointed | board shareholder meetings | low | — | — |
| 15 Sept 2026 · Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | compliance | minimal | — | — |
| 9 Sept 2026 · Company Secretary Raina Singh resigns from Arvee Laboratories | management changes | medium | — | — |
| 7 Aug 2026 · Q1 FY27 results: revenue up 130 percent YoY, PAT jumps to Rs 169.41 lakh | results | high | — | — |
| 4 Aug 2026 · Corrigendum to trading window closure date | compliance | minimal | — | — |
| 27 Jun 2026 · Trading window closure from July 1 ahead of Q1 results | compliance | minimal | — | — |
| 15 Jun 2026 · Promoter Disclosure: No New Share Encumbrance for FY 2025-26 | compliance | minimal | — | — |
| 19 May 2026 · Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | results | high | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.